The criteria for both Mounjaro and Wegovy are: BMI of 30 or above, or BMI of 27 or above with at least one weight-related health condition (such as type 2 diabetes, high blood pressure, or obstructive sleep apnoea) If your BMI is below 27, you wont currently be eligible for GLP-1 medication for weight management through the NHS or private prescribers in the UK 7,8
Consequently, it is crucial to explore alternative therapeutic options for managing these seizures
2.9 Statistical analysis We utilized the GraphPad Prism 9 statistical software (GraphPad Software, Inc., CA, United States) for all statistical analyses, presenting the outcomes as mean standard deviation (SD)
Research presented at the European Congress on Obesity in 2024, for instance, found that people who gradually reduced their dose to zero (over an average of nine weeks) maintained a stable body weight in the first 26 weeks after tapering
Both Second Nature and Boots offer the 7.2 mg dose, which was approved by the MHRA in January 2026
[16] Second, and most distinctively, T4 stimulates oligodendrocyte-progenitor differentiation and remyelination , apparently via p38 MAPK signaling, across stroke, TBI, and EAE models
